Hi asf,
i've had a go with my model...
Have attached two table - the first is the numbers without milestone payment - ie modeling royalty payments only:
The second is with full milestone payments included:
My numbers suggest strong upside value - assuming that: 1) Axiron can take further market share; and 2) that the overall US market grows; and 3) axiron can penetrate internal markets over time.
Happy to provide further detail behind my assumptions - at a high level i forecast market share expansion and growth out to 2017 (peak market share) and then fade it at -2%pa until 2021 - where i calculate terminal value. Generics will become a factor in the market and i don't believe market share will be held in the face of that... so all conservative stuff.
Happy to take any questions / criticisms... clearly the market does not see value here so what am i missing?
Regards,
mita
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.957M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 187500 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.7¢ | 358041 | 1 |
View Market Depth
| Last trade - 09.59am 07/08/2025 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable